BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-032 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-032@nextconsensus.com
DTSTAMP:20261015T000000Z
DTSTART;VALUE=DATE:20261212
DTEND;VALUE=DATE:20261213
SUMMARY:FF-032 deadline: Imsidolimab · generalized pustular psoriasis appr
 oval
DESCRIPTION:Registered forecast FF-032 (FDA)\, Imsidolimab · generalized p
 ustular psoriasis approval. It asks whether this happens by 2026-12-12. Th
 e record: https://nextconsensus.com/forecast/ff-032/
URL:https://nextconsensus.com/forecast/ff-032/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR